Occurrence of Kidney Stones

    Basic Details
    Date Posted
    Tuesday, February 25, 2014
    Medical Product
    anti-diabetic agent (ADA)
    Health Outcome(s)
    kidney stone

    Modular program-based one-time assessment of prevalence and incidence of kidney stones among all members and among those with a pre-existing condition of anti-diabetic agent (ADA) use. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2004 – December 31, 2012. Modular programs are adaptable standardized programs. Results were generated using Modular Program 9, version 1.0; click here for more information. Queries were distributed in August 2013. This report includes data from 18 Data Partners.

    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    Time Period
    2004 - 2012
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    All individuals
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)